Studies on third dose of COVID-19 vaccine offer ‘hope’ to immunocompromised people
A study published in the New England Journal of Medicine found that a third dose of the Moderna or Pfizer vaccine “significantly improved” its effectiveness in organ transplant recipients who take immunosuppressant drugs.
State’s second-largest health insurer slams Biogen for costly Alzheimer’s drug
A top executive at the state’s second-biggest health insurer has accused Biogen of putting “excessive corporate profits” ahead of the welfare of patients by charging $56,000 a year for its controversial new drug for Alzheimer’s disease. And he said the insurer is undecided about whether to cover it.
Backlash over FDA approval of Biogen’s Alzheimer’s drug is spreading
A top executive at the state’s second-biggest health insurer has accused Biogen of putting “excessive corporate profits” ahead of the welfare of patients by charging $56,000 a year for its controversial new drug for Alzheimer’s disease. And he said the insurer is undecided about whether to cover it.
Gary Washburn | On basketball
In hiring Ime Udoka as his replacement, Brad Stevens found the right man for the job
The 43-year-old Nets assistant checked all the boxes in making a strong connection with the new Celtics president of basketball operations.
Celtics to hire Nets assistant Ime Udoka as head coach
Seven things to know about the Celtics’ 18th head coach
The 43-year-old Nets assistant checked all the boxes in making a strong connection with the new Celtics president of basketball operations.
tara sullivan
It’s fascinating to watch the more forthcoming Tom Brady, and other thoughts
Freed from Bill Belichick’s zipped-lip environment, Brady continues to be more open about his thoughts and feelings than he was across two decades in New England.
Could there be an actual quarterback competition at Patriots camp in July?
Freed from Bill Belichick’s zipped-lip environment, Brady continues to be more open about his thoughts and feelings than he was across two decades in New England.
Support Real Journalism
Subscribe to the Globe for just 99 cents